Amyris, Inc.

Equities

AMRSQ

US03236M2008

Specialty Chemicals

Market Closed - OTC Markets 03:41:48 2024-03-28 pm EDT 5-day change 1st Jan Change
0.006 USD +200.00% Intraday chart for Amyris, Inc. +20.00% +140.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Stock Futures -2- DJ
Third Amended Joint Reorganization Plan Filed by Amyris, Inc. CI
Notice for Auction Cancellation Filed by Amyris, Inc. CI
Foris Ventures Provides Information to the Shareholders CI
Advance Auto Parts Names Elizabeth Dreyer as Chief Accounting Officer MT
First Motion for Exclusivity Period Extension Approved For Amyris, Inc. CI
Amyris, Inc., Amyris Clean Beauty, Inc., and Aprinnova, LLC Enter into Amendment to That Certain Senior Secured Super Priority Debtor in Possession Loan Agreement CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Dr. Reddy's Laboratories Acquires MenoLabs Business MT
Mounting Geopolitical Tensions Weigh Down Indian Equities on Wednesday MT
Dr. Reddy's Acquires Women's Health and Diery Supplements Brand MenoLabs MT
Amyris, Inc. cancelled the transaction announced on December 29, 2022 CI
Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024 CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Bidding Procedure Approved for Amyris, Inc. CI
Motion for Asset Sale Filed by Amyris, Inc. CI
Notice of Selection of Successful Bidder by Amyris, Inc. CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Motion for Asset Sale Approved for Amyris, Inc. CI
Motion for Asset Sale Approved for Amyris, Inc. CI
First Motion for Exclusivity Period Extension Filed by Amyris, Inc. CI
Second Amended Reorganization Plan Filed by Amyris, Inc. CI
THG buys skincare brand Biossance for USD20 million AN
Chart Amyris, Inc.
More charts
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company's sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock
  2. Equities
  3. Stock Amyris, Inc. - OTC Markets
  4. News Amyris, Inc.
  5. Amyris : to Acquire Terasana Brand to Expand Range of Cannabinoid Consumer Products